Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli)

NCT06314880 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL: Recombinant Meningococcal Group B Vaccine (E. Coli) (low-dose)
BIOLOGICAL: Recombinant Meningococcal Group B Vaccine (E. Coli) (hign-dose)
BIOLOGICAL: Placebo control

Sponsor

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd